港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

巨子生物

71.400

+0.1500.21%

成交量：364.43萬

成交額：2.60億

市值：739.70億

市盈率：31.90

高：73.350

開：70.100

低：68.850

收：71.250

資料載入中...

總覽公司新聞公告

《大行》招銀國際微升鉅子生物(02367.HK)目標價至69.19元公司上調去年業績指引

阿斯达克财经

鉅子生物1月16日遭南向資金減持77.30萬股

鉅子生物2024年線上增速靚麗，上調業績指引

鉅子生物持續上漲超4% 大摩給予“增持”評級

花旗：重申鉅子生物(02367)“買入”評級目標價上調至61港元

智通财经网

【港股通】鉅子生物(02367)漲4.62% 花旗升其目標價3% 料去年收入按年增52% 淨利潤增40%

異動解讀 | 鉅子生物因盈利持續增長和旗下品牌表現強勁盤中大漲5.03%

鉅子生物盤中異動早盤股價大漲5.03%

港股異動 | 鉅子生物(02367)漲超4% 旗下兩大品牌增長強勁大摩看好公司全年業績表現

鉅子生物1月13日收盤下跌1.42%，成交1.3億港元

鉅子生物：妝品業務結構優化醫療器械合規化加速

【券商聚焦】高盛指本土化妝品品牌持續增長整體跑贏跨國公司

【港股通】鉅子生物(02367)漲超6% 大摩料其全年業績較其他所覆蓋公司更強

鉅子生物現漲逾6% 大摩認為公司業務仍處於強勁的擴張週期

【港股異動 | 鉅子生物(02367.HK)漲超4% 】鉅子生物(02367.HK)漲超4%，截至發稿，漲4.31%，報48.35港元，成交額3146.62萬港元。

港股異動 | 鉅子生物(02367)漲超4% 大摩認為公司業務仍處於強勁的擴張週期

鉅子生物盤中異動股價大漲5.07%報48.700港元

南向資金1月8日淨賣出鉅子生物91.55萬股連續5日減持

大摩：予鉅子生物“增持”評級目標價65港元

【大摩：予鉅子生物(02367.HK)“增持”評級目標價65港元】摩根士丹利發佈研究報告稱，預期鉅子生物(02367.HK)未來15天股價有約70%至80%錄得上升，並將其目標價定於65港元，給予“增持”評級。該行預計公司2024及2025財年的盈利增長，將分別為37%和23%，即將公佈的全年業績或較該行覆蓋範圍內的其他公司更強。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":71.4,"timestamp":1743667696030,"preClose":71.25,"halted":0,"volume":3644322,"delay":0,"floatShares":1036000000,"shares":1036000000,"eps":2.2379370699542087,"marketStatus":"休市中","change":0.15,"latestTime":"04-03 16:08:16","open":70.1,"high":73.35,"low":68.85,"amount":260403832,"amplitude":0.063158,"askPrice":71.5,"askSize":7600,"bidPrice":71.4,"bidSize":28400,"shortable":3,"etf":0,"ttmEps":2.1949438527447582,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":7,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":71.25,"dividendRate":0.013585,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"volumeRatio":0.6335034764670934,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1036000000,"roa":"21.88%","roe":"35.88%","lyrEps":2.237937,"volumeRatio":0.6335034764670934,"shares":1036000000,"dividePrice":0.97,"high":73.35,"amplitude":0.063158,"preClose":71.25,"low":68.85,"week52Low":35,"pbRate":"9.77","psRate":"12.53","week52High":75.2,"institutionHeld":0,"latestPrice":71.4,"committee":0.577778,"eps":2.2379370699542087,"divideRate":0.013585,"volume":3644322,"delay":0,"ttmEps":2.1949438527447582,"open":70.1,"prevYearClose":49.9,"prevWeekClose":68,"prevMonthClose":70.45,"prevQuarterClose":70.45,"fiveDayClose":67.45,"twentyDayClose":70.35,"sixtyDayClose":46.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2504658977","title":"《大行》招銀國際微升鉅子生物(02367.HK)目標價至69.19元  公司上調去年業績指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2504658977","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504658977?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 09:57","pubTimestamp":1737079020,"startTime":"0","endTime":"0","summary":"招银国际发表研究报告指，巨子生物(02367.HK) 的可复美及可丽金线上GMV增长亮眼，集团上调其去年业绩指引，预计收入增长逾50%，纯利升约40%。该行继续看好公司护肤产线在今年保持快速增长，并期待首款重组胶原蛋白注射类产品在于今年首季获批。招银国际表示，考虑到巨子生物调升收入指引，且优于预期，因此将集团2023至25财年的收入年复合增长率增至43.5%。该行维持集团的“买入”评级，将目标价由66.15元升至69.19元。(sl/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-16 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221209170559652_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221209170559652_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1411256&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367"],"gpt_icon":0},{"id":"2504979537","title":"鉅子生物1月16日遭南向資金減持77.30萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2504979537","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504979537?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 09:30","pubTimestamp":1737077421,"startTime":"0","endTime":"0","summary":"1月16日，南向资金减持巨子生物77.30万股。截止当日收盘，港股通共持有巨子生物16573.14万股，占流通股16.11%。巨子生物近5个交易日上涨14.99%，港股通累计减持247.10万股；近20个交易日上涨3.29%，港股通累计减持579.10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117093151abade132&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117093151abade132&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2503471652","title":"鉅子生物2024年線上增速靚麗，上調業績指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2503471652","media":"招银国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503471652?lang=zh_tw&edition=fundamental","pubTime":"2025-01-15 10:16","pubTimestamp":1736907373,"startTime":"0","endTime":"0","summary":"2024年收官，可复美和可丽金线上GMV增长亮眼。公司上调2024年业绩指引，预期收入增长50+%，归母净利润增长40%左右。魔镜数据显示，巨子生物旗下可复美品牌的美容护肤品类2024年在天猫淘宝渠道的GMV增速高达42%，在猫淘渠道排名第二，仅次于儒意。2024年，可复美和可丽金在猫淘、京东、抖音的GMV共计达54亿元，同比增长57%。我们预期胶原棒和焦点面霜将在2025年继续驱动可复美品牌的快速增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115103039abab5707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115103039abab5707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2503115593","title":"鉅子生物持續上漲超4% 大摩給予“增持”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2503115593","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503115593?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 11:17","pubTimestamp":1736824620,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　巨子生物（02367）早盘持续走高，股价上涨5.23%，现报51.30港元，成交额1.08亿港元。\n　　摩根士丹利研报指出，预期巨子生物未来15天股价有约70%至80%取得上升，并将其目标价定于65港元，给予“增持”评级。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-01-14/doc-ineexcec8857743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2503655598","title":"花旗：重申鉅子生物(02367)“買入”評級 目標價上調至61港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503655598","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503655598?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 10:40","pubTimestamp":1736822410,"startTime":"0","endTime":"0","summary":"花旗预计巨子生物2024年收入将同比增52%。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20250114/20250114104025_31640.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250114/20250114104025_31640.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1237194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02367"],"gpt_icon":0},{"id":"2503540560","title":"【港股通】鉅子生物(02367)漲4.62% 花旗升其目標價3% 料去年收入按年增52% 淨利潤增40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503540560","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503540560?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 10:35","pubTimestamp":1736822109,"startTime":"0","endTime":"0","summary":"金吾财讯 | 巨子生物 股价持续攀高，截止发稿，报51港元，涨4.62%，成交额7508.2万港元。消息面上，花旗发研报指，预计巨子生物2024年收入将按年增52%，净利润按年增40%，与管理层指引增长一致。考虑到巨子生物2024年4月配股后股权被轻微摊薄，花旗预计集团3年净利润复合年增长率为29%，每股盈利复合年增长率为28%。由于预测上调，基于2024年28倍的市盈率不变，该行将其目标价由59.5港元上调3%至61港元。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951359","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","HSCEI","02367","07226","YANG"],"gpt_icon":0},{"id":"1118635237","title":"異動解讀 | 鉅子生物因盈利持續增長和旗下品牌表現強勁盤中大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118635237","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118635237?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 10:32","pubTimestamp":1736821954,"startTime":"0","endTime":"0","summary":"今日盘中,巨子生物股价大涨5.03%,引起市场广泛关注。\n\n消息面上,券商机构看好公司未来表现。摩根士丹利最新研报预期巨子生物未来15天股价有约70%至80%上升空间,目标价为65港元,给予\"增持\"评级。该行预计公司2024及2025财年盈利分别增长37%和23%,高于同行业公司,即将公布的全年业绩或更为强劲。\n\n同时公司旗下两大品牌可复美和可丽金在去年\"双11\"大促期间再创佳绩,线上全渠道GMV分别同比增长80%+和150%+,支撑公司达成全年盈利目标。巨子生物作为全球重组胶原蛋白领导者,主要研发产销专业皮肤护理产品,属于高增长赛道,具备增长确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02367"],"gpt_icon":0},{"id":"2503050664","title":"鉅子生物盤中異動 早盤股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503050664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503050664?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 10:31","pubTimestamp":1736821897,"startTime":"0","endTime":"0","summary":"2025年01月14日早盘10时31分，巨子生物股票出现波动，股价快速上涨5.03%。截至发稿，该股报51.200港元/股，成交量138.86万股，换手率0.14%，振幅4.92%。巨子生物股票所在的生物技术行业中，整体涨幅为2.22%。其相关个股中，百济神州、华康生物医学、方达控股涨幅较大，振幅较大的相关个股有复宏汉霖、华昊中天医药-B、康宁杰瑞制药-B，振幅分别为8.22%、8.06%、7.43%。巨子生物公司简介：巨子生物控股有限公司是一家中国的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114103138aba9e55a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114103138aba9e55a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2503674895","title":"港股異動 | 鉅子生物(02367)漲超4% 旗下兩大品牌增長強勁 大摩看好公司全年業績表現","url":"https://stock-news.laohu8.com/highlight/detail?id=2503674895","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503674895?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 10:21","pubTimestamp":1736821300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物涨超4%，截至发稿，涨4.31%，报50.85港元，成交额6198.34万港元。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。去年“双11”期间，巨子生物旗下两大品牌可复美及可丽金再次实现高增。根据公司“双11”战报，可复美与可丽金线上全渠道GMV分别同比增长80%+和150%+。浦银国际认为，公司两大品牌在“双11”大促期间高速的增长支撑公司达成全年盈利目标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1237186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 巨子生物(02367)涨超4% 旗下两大品牌增长强劲 大摩看好公司全年业绩表现","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2028103732.USD","LU2089284900.SGD","LU0225283273.USD","BK4504","LU1989772923.USD","LU0106261372.USD","LU1162221912.USD","LU2023251221.USD","BK4516","BK1207","LU2271345857.HKD","LU0158827948.USD","LU1989772840.SGD","BK4534","BK4585","LU2111349929.HKD","BK4588","LU0098860793.USD","BK4581","LU1732799900.SGD","LU1732800096.USD","LU0106831901.USD","LU0267386448.USD","LU0795875086.SGD","LU0795875169.SGD","LU0158827781.USD","LU1720051017.SGD","LU2357305700.SGD","LU1548497426.USD","LU0006306889.USD","LU1363072403.SGD","BK4127","LU1720051108.HKD","LU2488822045.USD","LU2089283258.USD","LU1668664300.SGD","LU2347655156.SGD","LU1074936037.SGD","IE00BKVL7J92.USD","02367","LU0314104364.USD","LU0912757837.SGD","LU0320765646.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2503758582","title":"鉅子生物1月13日收盤下跌1.42%，成交1.3億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503758582","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503758582?lang=zh_tw&edition=fundamental","pubTime":"2025-01-13 17:02","pubTimestamp":1736758961,"startTime":"0","endTime":"0","summary":"1月13日，截至港股收盘，恒生指数下跌1%，报18874.14点。巨子生物收报48.75港元/股，下跌1.42%，成交量264.42万股，成交额1.3亿港元，振幅2.83%。最近一个月来，巨子生物累计跌幅5.61%，今年来累计跌幅2.3%，跑赢恒生指数-5.91%的跌幅。财务数据显示，截至2024年6月30日，巨子生物实现营业总收入25.4亿元，同比增长58.21%；归母净利润9.83亿元，同比增长47.41%；毛利率82.4%，资产负债率23.21%。利用专有的合成生物学技术设计及开发重组胶原蛋白、稀有人参皂苷及其他生物活性成分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011317062898648533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011317062898648533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2502808879","title":"鉅子生物：妝品業務結構優化 醫療器械合規化加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2502808879","media":"国联证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502808879?lang=zh_tw&edition=fundamental","pubTime":"2025-01-11 00:00","pubTimestamp":1736524800,"startTime":"0","endTime":"0","summary":"2024 年12 月17 日，巨子生物获得骨修复材料III 类医疗器械注册证。妆品业务结构优化，医疗器械合规化加速，维持“买入”评级考虑到公司双11 期间亮眼表现，我们预计公司2024-2026 年收入分别为53.11/66.49/80.69 亿元，对应增速分别为50.7%/25.2%/21.4%；归母净利润分别为20.37/24.65/30.14 亿元， 对应增速分别为40.3%/21.0%/22.3% ； EPS 分别为1.98/2.40/2.93 元/股，对应3 年复合增速为27.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111163629a21dd73c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111163629a21dd73c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","09997","02367","BK1100","09996","LU2488822045.USD","BK1207","BK1222"],"gpt_icon":0},{"id":"2502881051","title":"【券商聚焦】高盛指本土化妝品品牌持續增長 整體跑贏跨國公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2502881051","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502881051?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 14:30","pubTimestamp":1736490611,"startTime":"0","endTime":"0","summary":"整体来看，2024年本土品牌总体表现优于跨国公司品牌，巨子生物、韩束、毛戈平同比增长67%、56%、57%，而除LGHH增长18%外，多数跨国公司品牌呈下降趋势。在估值方面，中国化妆品公司仍低于历史平均水平，市盈率为22.3倍12个月预期市盈率，而全球化妆品公司为26倍。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951186","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4552","BK4588","LU0106831901.USD","BK4127","IE0004086264.USD","LU2237443622.USD","BK4516","LU2237443978.SGD","IE0034235188.USD","BK4585","IE00BFXG1179.USD","BK1207","BK4550","01318","IE0002270589.USD","IE00BSNM7G36.USD","LU2237438978.USD","BK4533","LU2237443382.USD","LU2237443465.HKD","IE0004091025.USD","02367","LU1791807156.HKD","BK4504","LU2488822045.USD","IE00B19Z3B42.SGD","LU2237443549.SGD","LU1668664300.SGD","IE00B19Z3581.USD","LU2237443895.HKD"],"gpt_icon":0},{"id":"2502500619","title":"【港股通】鉅子生物(02367)漲超6% 大摩料其全年業績較其他所覆蓋公司更強","url":"https://stock-news.laohu8.com/highlight/detail?id=2502500619","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502500619?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 10:24","pubTimestamp":1736475872,"startTime":"0","endTime":"0","summary":"金吾财讯 | 巨子生物(02367)早盘股价发力走高，最新报49.15港元，涨6.04%，成交额1亿港元。消息面上，摩根士丹利发研报指，预期巨子生物未来15天股价有约70%至80%录得上升。该行指，巨子生物股价自去年12月中旬以来已下跌约12%，该行暂未看到根本原因，但认为相关表现主要受市场配置所影响。该行认为，若以2025年预计的18倍市盈率交易，可以看到令人信服的风险及回报，因为该公司业务仍处于强劲的扩张周期。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。予目标价65港元，给予“增持”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1951160","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU2488822045.USD","LU1668664300.SGD","LU1720051017.SGD","IE00BZ1G4Q59.USD","LU0912757837.SGD","LU0006306889.USD","LU0314104364.USD","LU0795875086.SGD","LU2347655156.SGD","LU0158827948.USD","LU0267386448.USD","HSTECH","LU2271345857.HKD","IE00BKVL7J92.USD","LU1732800096.USD","LU2028103732.USD","LU0795875169.SGD","BK4581","LU0106261372.USD","LU0320765646.SGD","LU2023251221.USD","LU1548497426.USD","LU2089283258.USD","LU2111349929.HKD","LU1989772923.USD","LU2089284900.SGD","02367","LU1720051108.HKD","07226","BK4516","LU1363072403.SGD","BK4585","LU0098860793.USD","BK4534","LU1989772840.SGD","HSCEI","LU1732799900.SGD","YANG","BK1207","LU0225283273.USD","LU2357305700.SGD","BK4127","LU0971096721.USD","LU1074936037.SGD","BK4504","LU1162221912.USD","LU0158827781.USD","BK4588"],"gpt_icon":0},{"id":"2502170006","title":"鉅子生物現漲逾6% 大摩認為公司業務仍處於強勁的擴張週期","url":"https://stock-news.laohu8.com/highlight/detail?id=2502170006","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502170006?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 10:19","pubTimestamp":1736475540,"startTime":"0","endTime":"0","summary":"　　巨子生物早盘上涨5.93%，现报49.10港元，成交额9726.53万港元。　　大摩发布研究报告称，预期巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。　　报告中称，巨子生物股价自去年12月中旬以来已下跌约12%，该行暂未看到根本原因，但认为相关表现主要受市场配置所影响。该行认为，若以2025年预计的18倍市盈率交易，可以看到令人信服的风险及回报，因为该公司业务仍处于强劲的扩张周期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-01-10/doc-ineenauc6317708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2028103732.USD","LU2089284900.SGD","LU1162221912.USD","BK4516","BK4127","LU2023251221.USD","BK4588","LU2357305700.SGD","LU1363072403.SGD","LU1732800096.USD","LU1668664300.SGD","LU2488822045.USD","02367","LU0106261372.USD","LU0795875169.SGD","LU1732799900.SGD","LU1074936037.SGD","LU2089283258.USD","LU1720051108.HKD","LU1720051017.SGD","IE00BKVL7J92.USD","LU1548497426.USD","LU2347655156.SGD","BK4534","LU0320765646.SGD","LU0158827781.USD","BK4585","LU0158827948.USD","LU0225283273.USD","LU0106831901.USD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU2111349929.HKD","LU0006306889.USD","BK1207","LU0795875086.SGD","BK4504","LU1989772840.SGD","LU0267386448.USD","LU0314104364.USD","LU0912757837.SGD","BK4581","LU0098860793.USD","LU1989772923.USD","LU2271345857.HKD"],"gpt_icon":0},{"id":"2502003269","title":"【港股異動 | 鉅子生物(02367.HK)漲超4% 】鉅子生物(02367.HK)漲超4%，截至發稿，漲4.31%，報48.35港元，成交額3146.62萬港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502003269","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502003269?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 09:56","pubTimestamp":1736474190,"startTime":"0","endTime":"0","summary":"巨子生物(02367.HK)涨超4%，截至发稿，涨4.31%，报48.35港元，成交额3146.62万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/10095647326493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2502003631","title":"港股異動 | 鉅子生物(02367)漲超4% 大摩認為公司業務仍處於強勁的擴張週期","url":"https://stock-news.laohu8.com/highlight/detail?id=2502003631","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502003631?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 09:39","pubTimestamp":1736473161,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物(02367)涨超4%，截至发稿，涨4.31%，报48.35港元，成交额3146.62万港元。大摩发布研究报告称，预期巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。报告中称，巨子生物股价自去年12月中旬以来已下跌约12%，该行暂未看到根本原因，但认为相关表现主要受市场配置所影响。该行认为，若以2025年预计的18倍市盈率交易，可以看到令人信服的风险及回报，因为该公司业务仍处于强劲的扩张周期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1235823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BKVL7J92.USD","LU2357305700.SGD","LU1989772840.SGD","LU0795875169.SGD","LU0795875086.SGD","LU1548497426.USD","LU1989772923.USD","LU0320765646.SGD","LU0158827948.USD","LU2111349929.HKD","LU2347655156.SGD","LU0158827781.USD","LU2488822045.USD","LU0006306889.USD","LU0912757837.SGD","LU1074936037.SGD","LU2089284900.SGD","LU0106831901.USD","LU0106261372.USD","BK4516","LU1363072403.SGD","BK4588","LU2028103732.USD","BK4127","LU1720051017.SGD","LU0098860793.USD","LU2089283258.USD","BK4585","LU2271345857.HKD","02367","BK4504","LU2023251221.USD","LU1720051108.HKD","LU0314104364.USD","LU1162221912.USD","LU1732799900.SGD","LU1732800096.USD","IE00BZ1G4Q59.USD","BK4581","LU0971096721.USD","LU1668664300.SGD","BK4534","LU0267386448.USD","BK1207","LU0225283273.USD"],"gpt_icon":0},{"id":"2502968268","title":"鉅子生物盤中異動 股價大漲5.07%報48.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502968268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502968268?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 09:30","pubTimestamp":1736472623,"startTime":"0","endTime":"0","summary":"2025年01月10日早盘09时30分，巨子生物股票出现异动，股价大幅上涨5.07%。截至发稿，该股报48.700港元/股，成交量9200股，换手率0.00%，振幅3.88%。资金方面，该股资金流入19.175万港元，流出6.566万港元。巨子生物股票所在的生物技术行业中，整体涨幅为0.23%。该信息摘要如下：摩根士丹利发布研究报告称，预期巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011009302398610724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011009302398610724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2502354034","title":"南向資金1月8日淨賣出鉅子生物91.55萬股 連續5日減持","url":"https://stock-news.laohu8.com/highlight/detail?id=2502354034","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502354034?lang=zh_tw&edition=fundamental","pubTime":"2025-01-09 09:30","pubTimestamp":1736386222,"startTime":"0","endTime":"0","summary":"1月8日，南向资金减持巨子生物91.55万股连续5日减持。截止当日收盘，港股通共持有巨子生物16881.92万股，占流通股16.41%。港股通减持金额前五个股分别为小鹏汽车-W、华润啤酒、碧桂园服务、雅迪控股、安踏体育。巨子生物近5个交易日下跌7.31%，港股通累计减持182.33万股；近20个交易日下跌9.84%，港股通累计减持381.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109093259aba3dc74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109093259aba3dc74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2501743860","title":"大摩：予鉅子生物“增持”評級 目標價65港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501743860","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501743860?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 17:09","pubTimestamp":1736327340,"startTime":"0","endTime":"0","summary":"　　摩根士丹利发布研究报告称，预期巨子生物未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。　　报告中称，巨子生物股价自去年12月中旬以来已下跌约12%，该行暂未看到根本原因，但认为相关表现主要受市场配置所影响。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-01-08/doc-ineehfmt0430836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2501710704","title":"【大摩：予鉅子生物(02367.HK)“增持”評級 目標價65港元】摩根士丹利發佈研究報告稱，預期鉅子生物(02367.HK)未來15天股價有約70%至80%錄得上升，並將其目標價定於65港元，給予“增持”評級。該行預計公司2024及2025財年的盈利增長，將分別為37%和23%，即將公佈的全年業績或較該行覆蓋範圍內的其他公司更強。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501710704","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501710704?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 16:59","pubTimestamp":1736326785,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研究报告称，预期巨子生物(02367.HK)未来15天股价有约70%至80%录得上升，并将其目标价定于65港元，给予“增持”评级。该行预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/08165947255704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02367"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":18,"updateTime":1743177600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-03","current":32.960917,"percent":0.76819,"low":18.546195,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"high":60.214956,"avg":30.40921,"sd":6.612573,"marketCap":72606945600},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600}],"updateTime":1743926185465}}}